Titre:
  • Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-term Care Facilities: Data From the GeroCovid Vax Study.
Auteur:Virgilio, Enrico; Trevisan, Caterina; Abbatecola, Angela; Malara, Alba; Palmieri, Annapina; Fedele, Giorgio; Stefanelli, Paola; Leone, Pasqualina; Schiavoni, Ilaria; Maggi, Stefania; Volpato, Stefano; Antonelli Incalzi, Raffaele; Onder, Graziano; GeroCovid Vax Working Group,
Informations sur la publication:Diabetes care, 45, 12, page (2935-2942)
Statut de publication:Publié, 2022-12
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Female
Humans
Aged
Aged, 80 and over
Male
COVID-19 Vaccines
SARS-CoV-2
Antibody Formation
Diabetes Mellitus, Type 2
Long-Term Care
COVID-19
Insulin
Hypoglycemic Agents
Vaccination
Insulin, Regular, Human
Immunoglobulin G
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0149-5992
info:doi/10.2337/dc22-1255
info:pii/147714
info:scp/85143273368
info:pmid/36201657